The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles

New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A 1 and/or A 2A receptor subtypes. On the whole, the novel derivatives 1-24 share...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of enzyme inhibition and medicinal chemistry 2017-01, Vol.32 (1), p.248-263
Hauptverfasser: Squarcialupi, Lucia, Betti, Marco, Catarzi, Daniela, Varano, Flavia, Falsini, Matteo, Ravani, Annalisa, Pasquini, Silvia, Vincenzi, Fabrizio, Salmaso, Veronica, Sturlese, Mattia, Varani, Katia, Moro, Stefano, Colotta, Vittoria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 263
container_issue 1
container_start_page 248
container_title Journal of enzyme inhibition and medicinal chemistry
container_volume 32
creator Squarcialupi, Lucia
Betti, Marco
Catarzi, Daniela
Varano, Flavia
Falsini, Matteo
Ravani, Annalisa
Pasquini, Silvia
Vincenzi, Fabrizio
Salmaso, Veronica
Sturlese, Mattia
Varani, Katia
Moro, Stefano
Colotta, Vittoria
description New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A 1 and/or A 2A receptor subtypes. On the whole, the novel derivatives 1-24 shared scarce or no affinities for the off-target hA 2B and hA 3 ARs. The 5-(4-hydroxyphenethylamino)- derivative 12 showed both good affinity (K i = 150 nM) and the best selectivity for the hA 2A AR while the 5-benzylamino-substituted 5 displayed the best combined hA 2A (K i = 123 nM) and A 1 AR affinity (K i = 25 nM). The 5-phenethylamino moiety (compound 6) achieved nanomolar affinity (K i = 11 nM) and good selectivity for the hA 1 AR. The 5-(N 4 -substituted-piperazin-1-yl) derivatives 15-24 bind the hA 1 AR subtype with affinities falling in the high nanomolar range. A structure-based molecular modeling study was conducted to rationalize the experimental binding data from a molecular point of view using both molecular docking studies and Interaction Energy Fingerprints (IEFs) analysis.
doi_str_mv 10.1080/14756366.2016.1247060
format Article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_journals_2195236301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3becb9391fc64475b2620dd24841af0a</doaj_id><sourcerecordid>2195236301</sourcerecordid><originalsourceid>FETCH-LOGICAL-d3560-9ed1df243f8b390edfa94377ee8b8c4fc4135e51cefcae617a046afa8909d8943</originalsourceid><addsrcrecordid>eNpVUl1rFDEUHUSxtfoThICvzpqvyUxexKVoLRR8qU8iIZPcbLNmkzEz27L-LH9hM7Or0Jck95xzT7iXU1VvCV4R3OEPhLeNYEKsKCZiRShvscDPqvMZrwVr-fP_byHOqlfjuMWYEkr4y-qMdoTwjjbn1d_bO0A5BUDJoabW-RB0-FWOnY-pRjragg5-gKz_LMgueZg8jChFNJXetl6kw6EIUkg_-HtW25-l9DtvfQRkUgbkI9LOgZl83CBtIaZx5tZk-WFN1yiDgWFKedb56KfDwowQ5qb7uR5ycj7A-Lp64XQY4c3pvqi-f_l8e_m1vvl2dX25vqktawSuJVhiHeXMdT2TGKzTkrO2Bej6znBnOGENNMSAMxoEaTXmQjvdSSxtV6QX1fXR1ya9VUMZqGxHJe3VAqS8UTpP3gRQrAfTSyaJM4KXpfdUUGwt5R0n2mFdvD4evYZ9vwNrIE5ZhyemT5no79Qm3SuBsZStLAbvTgY5_d7DOKlt2udY5leUyIYywTApqk9HlY8u5Z1-SDlYNelDSNllHY0fFSNYzQlS_xKk5gSpU4LYI8_wu1U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2195236301</pqid></control><display><type>article</type><title>The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles</title><source>Taylor &amp; Francis Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Squarcialupi, Lucia ; Betti, Marco ; Catarzi, Daniela ; Varano, Flavia ; Falsini, Matteo ; Ravani, Annalisa ; Pasquini, Silvia ; Vincenzi, Fabrizio ; Salmaso, Veronica ; Sturlese, Mattia ; Varani, Katia ; Moro, Stefano ; Colotta, Vittoria</creator><creatorcontrib>Squarcialupi, Lucia ; Betti, Marco ; Catarzi, Daniela ; Varano, Flavia ; Falsini, Matteo ; Ravani, Annalisa ; Pasquini, Silvia ; Vincenzi, Fabrizio ; Salmaso, Veronica ; Sturlese, Mattia ; Varani, Katia ; Moro, Stefano ; Colotta, Vittoria</creatorcontrib><description>New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A 1 and/or A 2A receptor subtypes. On the whole, the novel derivatives 1-24 shared scarce or no affinities for the off-target hA 2B and hA 3 ARs. The 5-(4-hydroxyphenethylamino)- derivative 12 showed both good affinity (K i = 150 nM) and the best selectivity for the hA 2A AR while the 5-benzylamino-substituted 5 displayed the best combined hA 2A (K i = 123 nM) and A 1 AR affinity (K i = 25 nM). The 5-phenethylamino moiety (compound 6) achieved nanomolar affinity (K i = 11 nM) and good selectivity for the hA 1 AR. The 5-(N 4 -substituted-piperazin-1-yl) derivatives 15-24 bind the hA 1 AR subtype with affinities falling in the high nanomolar range. A structure-based molecular modeling study was conducted to rationalize the experimental binding data from a molecular point of view using both molecular docking studies and Interaction Energy Fingerprints (IEFs) analysis.</description><identifier>ISSN: 1475-6366</identifier><identifier>EISSN: 1475-6374</identifier><identifier>DOI: 10.1080/14756366.2016.1247060</identifier><identifier>PMID: 28114825</identifier><language>eng</language><publisher>Abingdon: Taylor &amp; Francis</publisher><subject>Adenosine ; Adenosine A1 and A2A receptor antagonists ; Affinity ; G protein-coupled receptors ; ligand-receptor modeling studies ; Molecular modelling ; pyrazolo[4,3-d]pyrimidines</subject><ispartof>Journal of enzyme inhibition and medicinal chemistry, 2017-01, Vol.32 (1), p.248-263</ispartof><rights>2017 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group 2017</rights><rights>2017 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/Licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group 2017 The Author(s).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009979/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009979/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,27483,27905,27906,53772,53774,59122,59123</link.rule.ids></links><search><creatorcontrib>Squarcialupi, Lucia</creatorcontrib><creatorcontrib>Betti, Marco</creatorcontrib><creatorcontrib>Catarzi, Daniela</creatorcontrib><creatorcontrib>Varano, Flavia</creatorcontrib><creatorcontrib>Falsini, Matteo</creatorcontrib><creatorcontrib>Ravani, Annalisa</creatorcontrib><creatorcontrib>Pasquini, Silvia</creatorcontrib><creatorcontrib>Vincenzi, Fabrizio</creatorcontrib><creatorcontrib>Salmaso, Veronica</creatorcontrib><creatorcontrib>Sturlese, Mattia</creatorcontrib><creatorcontrib>Varani, Katia</creatorcontrib><creatorcontrib>Moro, Stefano</creatorcontrib><creatorcontrib>Colotta, Vittoria</creatorcontrib><title>The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles</title><title>Journal of enzyme inhibition and medicinal chemistry</title><description>New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A 1 and/or A 2A receptor subtypes. On the whole, the novel derivatives 1-24 shared scarce or no affinities for the off-target hA 2B and hA 3 ARs. The 5-(4-hydroxyphenethylamino)- derivative 12 showed both good affinity (K i = 150 nM) and the best selectivity for the hA 2A AR while the 5-benzylamino-substituted 5 displayed the best combined hA 2A (K i = 123 nM) and A 1 AR affinity (K i = 25 nM). The 5-phenethylamino moiety (compound 6) achieved nanomolar affinity (K i = 11 nM) and good selectivity for the hA 1 AR. The 5-(N 4 -substituted-piperazin-1-yl) derivatives 15-24 bind the hA 1 AR subtype with affinities falling in the high nanomolar range. A structure-based molecular modeling study was conducted to rationalize the experimental binding data from a molecular point of view using both molecular docking studies and Interaction Energy Fingerprints (IEFs) analysis.</description><subject>Adenosine</subject><subject>Adenosine A1 and A2A receptor antagonists</subject><subject>Affinity</subject><subject>G protein-coupled receptors</subject><subject>ligand-receptor modeling studies</subject><subject>Molecular modelling</subject><subject>pyrazolo[4,3-d]pyrimidines</subject><issn>1475-6366</issn><issn>1475-6374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNpVUl1rFDEUHUSxtfoThICvzpqvyUxexKVoLRR8qU8iIZPcbLNmkzEz27L-LH9hM7Or0Jck95xzT7iXU1VvCV4R3OEPhLeNYEKsKCZiRShvscDPqvMZrwVr-fP_byHOqlfjuMWYEkr4y-qMdoTwjjbn1d_bO0A5BUDJoabW-RB0-FWOnY-pRjragg5-gKz_LMgueZg8jChFNJXetl6kw6EIUkg_-HtW25-l9DtvfQRkUgbkI9LOgZl83CBtIaZx5tZk-WFN1yiDgWFKedb56KfDwowQ5qb7uR5ycj7A-Lp64XQY4c3pvqi-f_l8e_m1vvl2dX25vqktawSuJVhiHeXMdT2TGKzTkrO2Bej6znBnOGENNMSAMxoEaTXmQjvdSSxtV6QX1fXR1ya9VUMZqGxHJe3VAqS8UTpP3gRQrAfTSyaJM4KXpfdUUGwt5R0n2mFdvD4evYZ9vwNrIE5ZhyemT5no79Qm3SuBsZStLAbvTgY5_d7DOKlt2udY5leUyIYywTApqk9HlY8u5Z1-SDlYNelDSNllHY0fFSNYzQlS_xKk5gSpU4LYI8_wu1U</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Squarcialupi, Lucia</creator><creator>Betti, Marco</creator><creator>Catarzi, Daniela</creator><creator>Varano, Flavia</creator><creator>Falsini, Matteo</creator><creator>Ravani, Annalisa</creator><creator>Pasquini, Silvia</creator><creator>Vincenzi, Fabrizio</creator><creator>Salmaso, Veronica</creator><creator>Sturlese, Mattia</creator><creator>Varani, Katia</creator><creator>Moro, Stefano</creator><creator>Colotta, Vittoria</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170101</creationdate><title>The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles</title><author>Squarcialupi, Lucia ; Betti, Marco ; Catarzi, Daniela ; Varano, Flavia ; Falsini, Matteo ; Ravani, Annalisa ; Pasquini, Silvia ; Vincenzi, Fabrizio ; Salmaso, Veronica ; Sturlese, Mattia ; Varani, Katia ; Moro, Stefano ; Colotta, Vittoria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d3560-9ed1df243f8b390edfa94377ee8b8c4fc4135e51cefcae617a046afa8909d8943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenosine</topic><topic>Adenosine A1 and A2A receptor antagonists</topic><topic>Affinity</topic><topic>G protein-coupled receptors</topic><topic>ligand-receptor modeling studies</topic><topic>Molecular modelling</topic><topic>pyrazolo[4,3-d]pyrimidines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Squarcialupi, Lucia</creatorcontrib><creatorcontrib>Betti, Marco</creatorcontrib><creatorcontrib>Catarzi, Daniela</creatorcontrib><creatorcontrib>Varano, Flavia</creatorcontrib><creatorcontrib>Falsini, Matteo</creatorcontrib><creatorcontrib>Ravani, Annalisa</creatorcontrib><creatorcontrib>Pasquini, Silvia</creatorcontrib><creatorcontrib>Vincenzi, Fabrizio</creatorcontrib><creatorcontrib>Salmaso, Veronica</creatorcontrib><creatorcontrib>Sturlese, Mattia</creatorcontrib><creatorcontrib>Varani, Katia</creatorcontrib><creatorcontrib>Moro, Stefano</creatorcontrib><creatorcontrib>Colotta, Vittoria</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of enzyme inhibition and medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Squarcialupi, Lucia</au><au>Betti, Marco</au><au>Catarzi, Daniela</au><au>Varano, Flavia</au><au>Falsini, Matteo</au><au>Ravani, Annalisa</au><au>Pasquini, Silvia</au><au>Vincenzi, Fabrizio</au><au>Salmaso, Veronica</au><au>Sturlese, Mattia</au><au>Varani, Katia</au><au>Moro, Stefano</au><au>Colotta, Vittoria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles</atitle><jtitle>Journal of enzyme inhibition and medicinal chemistry</jtitle><date>2017-01-01</date><risdate>2017</risdate><volume>32</volume><issue>1</issue><spage>248</spage><epage>263</epage><pages>248-263</pages><issn>1475-6366</issn><eissn>1475-6374</eissn><abstract>New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A 1 and/or A 2A receptor subtypes. On the whole, the novel derivatives 1-24 shared scarce or no affinities for the off-target hA 2B and hA 3 ARs. The 5-(4-hydroxyphenethylamino)- derivative 12 showed both good affinity (K i = 150 nM) and the best selectivity for the hA 2A AR while the 5-benzylamino-substituted 5 displayed the best combined hA 2A (K i = 123 nM) and A 1 AR affinity (K i = 25 nM). The 5-phenethylamino moiety (compound 6) achieved nanomolar affinity (K i = 11 nM) and good selectivity for the hA 1 AR. The 5-(N 4 -substituted-piperazin-1-yl) derivatives 15-24 bind the hA 1 AR subtype with affinities falling in the high nanomolar range. A structure-based molecular modeling study was conducted to rationalize the experimental binding data from a molecular point of view using both molecular docking studies and Interaction Energy Fingerprints (IEFs) analysis.</abstract><cop>Abingdon</cop><pub>Taylor &amp; Francis</pub><pmid>28114825</pmid><doi>10.1080/14756366.2016.1247060</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1475-6366
ispartof Journal of enzyme inhibition and medicinal chemistry, 2017-01, Vol.32 (1), p.248-263
issn 1475-6366
1475-6374
language eng
recordid cdi_proquest_journals_2195236301
source Taylor & Francis Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adenosine
Adenosine A1 and A2A receptor antagonists
Affinity
G protein-coupled receptors
ligand-receptor modeling studies
Molecular modelling
pyrazolo[4,3-d]pyrimidines
title The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A08%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%205-arylalkylamino-%20and%205-piperazino-%20moieties%20on%20the%207-aminopyrazolo%5B4,3-d%5Dpyrimidine%20core%20in%20affecting%20adenosine%20A1%20and%20A2A%20receptor%20affinity%20and%20selectivity%20profiles&rft.jtitle=Journal%20of%20enzyme%20inhibition%20and%20medicinal%20chemistry&rft.au=Squarcialupi,%20Lucia&rft.date=2017-01-01&rft.volume=32&rft.issue=1&rft.spage=248&rft.epage=263&rft.pages=248-263&rft.issn=1475-6366&rft.eissn=1475-6374&rft_id=info:doi/10.1080/14756366.2016.1247060&rft_dat=%3Cproquest_infor%3E2195236301%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2195236301&rft_id=info:pmid/28114825&rft_doaj_id=oai_doaj_org_article_3becb9391fc64475b2620dd24841af0a&rfr_iscdi=true